EBC joined members of the Cancer Related Complications and Comorbidities Initiative in responding to the European Commission’s open consultation on the Roadmap for the Europe’s Beating Cancer Plan, which closed on 3 March 2020.

EBC joined the initiative of like-minded European health organisations in signing a joint statement calling for making cancer-related complications and comorbidities – many of which are neurological or psychiatric – an EU health priority. For example, depression affects 15-25 % of cancer patients, and cancer often affects the nervous system & can result in significant neurological morbidity and mortality. Around 15-20 % of cancer patients have neurological complications.

Though the Roadmap consultation closes on 3 March, the general public consultation remains open until 7 May 2020. We encourage all relevant stakeholders in the brain community to join us in making sure the brain and all related comorbidities are not left out of the cancer plan.

If you would like further information, have any questions or would like to join the initiative, please contact Stephanie Kramer (stkr@braincouncil.eu)

The full statement submitted can be read below:

comorbidities initiative response to Cancer Plan Roadmap consultation